for the compression group and 31% for the compression plus surgery group at 4 years, P
< 0.01).

Endovenous Treatment of Saphenous Refux
 Both EVLA and RFA are considered first-line therapies for the treatment of symptomatic
saphenous refux and are preferred over open surgery due to decreased postoperative
morbidity and reduced convalescence time [Gloviczki et al. (2024a